Neurocrine’s Ingrezza Adds Huntington’s Indication, May Have Competitive Edge

Extended-Release Rival Also Approved In 2023

 
• By Mandy Jackson
Leadership concept, One leader red sphere leads other boxes
Ingrezza sales already outpace Austedo • Source: Shutterstock

More from New Products

More from Scrip